We discovered that a considerable number of women with breast cancer and vision disturbance had serum anti-TULP1 AAbs, often coexisting with other anti-retinal AAbs, including a case of anti-recoverin and anti-Rab6A being present in the same patient. Here, RAB6A is linked to breast carcinoma.